CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Oct. 9, 2023—Bio SB has launched a fully automated immunohistochemistry platform for deparaffinization and antigen retrieval and staining. Applications include immunohistochemistry, Mohs IHC, immunocytochemistry, and immunofluorescence of formalin-fixed, paraffin-embedded tissue, frozen tissue, and cell specimens.
“Our new generation of new recombinant antibodies offers higher affinity, sensitivity, and specificity when compared to the previous generation of mouse monoclonal and polyclonal antibodies traditionally used in diagnostic immunohistochemistry applications,” Dr. Alfonso Heras, president and CEO of Bio SB, said in a press statement. “Additionally, our new platform uses our micropolymer Fab’ detection systems that enable us to detect the expression of biomarkers on tissue biopsies in five to 20 minutes, and it is especially suited for intraoperatory Mohs IHC.”